Knockdown of H19 enhances differentiation capacity to epidermis of parthenogenetic embryonic stem cells

Current Molecular Medicine

Volumn 14, Issue 6, 2014, Pages 737-748

  Yin, Y ^a   Wang, H ^a   Liu, K ^a   Wang, F ^a   Ye, X ^a   Liu, M ^a   Xiang, R ^a   Liu, N ^a   Liu, L ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Differentiation; H19; Parthenogenetic stem cells

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; RNA H19; TRANSCRIPTION FACTOR NANOG; H19 LONG NON-CODING RNA; LONG UNTRANSLATED RNA; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYOID BODY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE SILENCING; HISTOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; KERATINOCYTE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PARTHENOGENESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; TERATOMA; WESTERN BLOTTING; ANIMAL; CELL TRANSFORMATION; CYTOLOGY; EPIDERMIS; GENETICS; HEART MUSCLE CELL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; EMBRYONIC STEM CELLS; EPIDERMIS; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; INSULIN-LIKE GROWTH FACTOR II; MICE; MYOCYTES, CARDIAC; RECEPTOR, IGF TYPE 1; RNA INTERFERENCE; RNA, LONG NONCODING; SIGNAL TRANSDUCTION; TERATOMA;

EID: 84906255362     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666140724101035     Document Type: Article

References (57)

1. Yin Y, Liu N, Keefe DL, Liu L. Parthenogenetic Activation-Induced Pluripotent Stem Cells and Potential Applications. In: Hayat MA, editor. Stem Cells and Cancer Stem Cells: Springer Netherlands; 2012. p. 235-46.
2. Kono T, Obata Y, Wu Q, et al. Birth of parthenogenetic mice that can develop to adulthood. Nature 2004; 428:860-864.
3. Brevini TA, Gandolfi F. Parthenotes as a source of embryonic stem cells. Cell Prolif 2008; 41 (Suppl 1): 20-30.
4. De Sousa PA, Gardner J, Sneddon S, et al. Clinically failed eggs as a source of normal human embryo stem cells. Stem Cell Res 2009; 2: 188-197.
5. Kim K, Lerou P, Yabuuchi A, et al. Histocompatible embryonic stem cells by parthenogenesis. Science 2007; 315: 482-486.
6. Cibelli JB, Cunniff K, Vrana KE. Embryonic stem cells from parthenotes. Methods Enzymol 2006; 418: 117-135.
7. Hikichi T, Wakayama S, Mizutani E, et al. Differentiation potential of parthenogenetic embryonic stem cells is improved by nuclear transfer. Stem Cells 2007; 25: 46-53.
8. Jiang H, Sun B, Wang W, et al. Activation of paternally expressed imprinted genes in newly derived germline-competent mouse parthenogenetic embryonic stem cell lines. Cell Res 2007; 17: 792-803.
9. Liu Z, Hu Z, Pan X, et al. Germline competency of parthenogenetic embryonic stem cells from immature oocytes of adult mouse ovary. Hum Mol Genet 2011; 20: 1339-1352.
10. Fulka H, Hirose M, Inoue K, et al. Production of mouse embryonic stem cell lines from maturing oocytes by direct conversion of meiosis into mitosis. Stem Cells 2011; 29: 517-527.
11. Chen Z, Liu Z, Huang J, et al. Birth of parthenote mice directly from parthenogenetic embryonic stem cells. Stem Cells 2009; 27: 2136-2145.
12. Sanchez-Pernaute R, Lee H, Patterson M, et al. Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain 2008; 131: 2127-2139.
13. Didie M, Christalla P, Rubart M, et al. Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest 2013; 123: 1285-1298.
14. Liu Y, Ye X, Mao L, et al. Transplantation of parthenogenetic embryonic stem cells ameliorates cardiac dysfunction and remodelling after myocardial infarction. Cardiovas Res 2013; 97: 208-218.
15. Kono T. Genomic imprinting is a barrier to parthenogenesis in mammals. Cytogenet Genome Res 2006; 113: 31-15.
16. Liu N, Enkemann SA, Liang P, et al. Genome-wide gene expression profiling reveals aberrant MAPK and Wnt signaling pathways associated with early parthenogenesis. J Mol Cell Biol 2010; 2: 333-344.
17. Li C, Chen Z, Liu Z, et al. Correlation of expression and methylation of imprinted genes with pluripotency of parthenogenetic embryonic stem cells. Hum Mol Genet 2009; 18: 2177-2187.
18. Hu Z, Wang L, Xie Z, et al. Quantitative proteomics analysis of parthenogenetically induced pluripotent stem cells. Protein Cell 2011; 2: 631-646.
19. Kim MJ, Choi HW, Jang HJ, et al. Conversion of genomic imprinting by reprogramming and redifferentiation. J Cell Sci 2013; 126: 2516-2524.
20. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362-365.
21. Bartolomei MS, Zemel S, Tilghman SM. Parental imprinting of the mouse H19 gene. Nature 1991; 351: 153-155.
22. Zhang Y, Tycko B. Monoallelic expression of the human H19 gene. Nat Genet 1992; 1: 40-44.
23. Gabory A, Jammes H, Dandolo L. The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 2010; 32: 473-480.
24. Poirier F, Chan CT, Timmons PM, Robertson EJ, Evans MJ, Rigby PW. The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development 1991; 113: 1105-1114.
25. Ripoche MA, Kress C, Poirier F, Dandolo L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev 1997; 11: 1596-1604.
26. Leighton PA, Ingram RS, Eggenschwiler J, Efstratiadis A, Tilghman SM. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 1995; 375: 34-39.
27. Keniry A, Oxley D, Monnier P, et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012; 14: 659-665.
28. Brunkow ME, Tilghman SM. Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev 1991; 5: 1092-1101.
29. Fujimori H, Mukai H, Murakami Y, Hemberger M, Hippo Y, Masutani M. The H19 induction triggers trophoblast lineage commitment in mouse ES cells. Biochem Biophys Res Commun 2013; 436: 313-318.
30. Kawahara M, Wu Q, Takahashi N, et al. High-frequency generation of viable mice from engineered bi-maternal embryos. Nat Biotechnol 2007; 25: 1045-1050.
31. Gabory A, Ripoche MA, Le Digarcher A, et al. H19 acts as a trans regulator of the imprinted gene network controlling growth in mice. Development 2009; 136: 3413-3421.
32. Han L, Szabo PE, Mann JR. Postnatal survival of mice with maternal duplication of distal chromosome 7 induced by a Igf2/H19 imprinting control region lacking insulator function. PLoS Genet 2010; 6: e1000803.
33. Ragina NP, Schlosser K, Knott JG, et al. Downregulation of H19 improves the differentiation potential of mouse parthenogenetic embryonic stem cells. Stem Cells Dev 2012; 21: 1134-1144.
34. Huang J, Deng K, Wu H, et al. Efficient production of mice from embryonic stem cells injected into fouror eight-cell embryos by piezo micromanipulation. Stem Cells 2008; 26: 1883-1890.
35. Morita S, Kojima T, Kitamura T. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Therapy 2000; 7: 1063-1066.
36. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30: e47.
37. Callicott RJ, Womack JE. Real-time PCR assay for measurement of mouse telomeres. Comp Med 2006; 56: 17-22.
38. Wang F, Yin Y, Ye X, et al. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res 2012; 22: 757-768.
39. Sturm KS, Berger CN, Zhou SX, Dunwoodie SL, Tan S-S, Tam PPL. Unrestricted lineage differentiation of parthenogenetic ES cells. Dev Gene Evol 1997; 206: 377-388.
40. Alam H, Sehgal L, Kundu ST, Dalal SN, Vaidya MM. Novel function of keratins 5 and 14 in proliferation and differentiation of stratified epithelial cells. Mol Biol Cell 2011; 22: 4068-4078.
41. Byrne C, Tainsky M, Fuchs E. Programming gene expression in developing epidermis. Development 1994; 120: 2369-2383.
42. Green H, Easley K, Iuchi S. Marker succession during the development of keratinocytes from cultured human embryonic stem cells. Proc Natl Acad Sci U S A 2003; 100: 15625-15630.
43. Yao JY, Chen JK. Roles of p63 in epidermal development and tumorigenesis. Biomed J 2013; 35: 457-463.
44. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999; 398: 708-713.
45. Romano RA, Birkaya B, Sinha S. A functional enhancer of keratin14 is a direct transcriptional target of deltaNp63. J Invest Dermatol 2007; 127: 1175-1186.
46. Fonoudi H, Yeganeh M, Fattahi F, et al. ISL1 protein transduction promotes cardiomyocyte differentiation from human embryonic stem cells. PLoS One 2013; 8: e55577.
47. Akazawa H, Komuro I. Cardiac transcription factor Csx/Nkx2-5: Its role in cardiac development and diseases. Pharmacol Ther 2005; 107: 252-268.
48. Huang J, Min Lu M, Cheng L, et al. Myocardin is required for cardiomyocyte survival and maintenance of heart function. Proc Natl Acad Sci U S A 2009; 106: 18734-18739.
49. Song K, Nam YJ, Luo X, et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012; 485: 599-604.
50. Venkatraman A, He XC, Thorvaldsen JL, et al. Maternal imprinting at the H19-Igf2 locus maintains adult haematopoietic stem cell quiescence. Nature 2013; 500: 345-349.
51. Sadagurski M, Yakar S, Weingarten G, et al. Insulin-Like Growth Factor 1 Receptor Signaling Regulates Skin Development and Inhibits Skin Keratinocyte Differentiation. Mol Cell Biol 2006; 26: 2675-2687.
52. Heike CL, Cunningham ML, Steiner RD, et al. Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis? Am J Med Genet Part A 2005; 139A: 67-77.
53. Laustsen PG, Russell SJ, Cui L, et al. Essential role of insulin and insulin-like growth factor 1 receptor signaling in cardiac development and function. Mol Cell Biol 2007; 27: 1649-1664.
54. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993; 75: 59-72.
55. Peng XD, Xu PZ, Chen ML, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 2003; 17: 1352-1365.
56. Leeb M, Walker R, Mansfield B, Nichols J, Smith A, Wutz A. Germline potential of parthenogenetic haploid mouse embryonic stem cells. Development 2012; 139: 3301-3305.
57. Horii T, Kimura M, Morita S, Nagao Y, Hatada I. Loss of genomic imprinting in mouse parthenogenetic embryonic stem cells. Stem Cells 2008; 26: 79-88.